Imagene AI logo

Imagene AI

Imagene AI delivers precision Oncology Intelligence through robust multimodal foundation models and proprietary real-world data, accelerating biomarker discovery, patient stratification, response prediction, and companion diagnostic development. From H&E-based molecular profiling to AI-IHC companion diagnostics, Imagene AI develops AI-powered pathology assays that translate biological insight into patient selection and diagnostic strategies. Imagene AI collaborates with leading biopharma organizations to advance biomarker-driven programs from discovery through clinical development and deployment. For more information, visit www.imagene-ai.com.

Content by Imagene AI

IHC tissue section with AI cell segmentation overlays color-coded by biomarker expression intensity for quantitative companion diagnostic scoring.
| 4 min read
Industry Perspectives
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Researcher examining a multiwell plate alongside cell culture dishes in a laboratory.
Skip RNA purification for faster RT-qPCR workflows
Explore how direct cell lysis can reduce sample preparation steps and support efficient gene expression analysis by RT-qPCR.
Webinars
Thermo Fisher Scientific
Abstract rainbow-colored beams of light spreading across a dark background.
How to choose the right fluorochromes for complex flow cytometry panels
Compare fluorochromes based on resolution, spillover, antigen expression, and other factors that can affect panel performance.
Whitepaper
BD Bio
Illustration of multiple glowing blue and purple spherical cells against a dark blue background.
Technology Guide: High-content analysis in modern drug discovery
As researchers embrace more complex cellular models, high-content analysis brings new opportunities and challenges to drug discovery.
Technology Guides
Yokogawa